Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genoil Inc.

http://www.genoil.net

Latest From Genoil Inc.

Execs On The Move, July 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Execs On The Move, February 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Execs On The Move, October 2013

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Cycloset is first diabetes drug to clear US CV safety hurdle

VeroScience/S2 Therapeutics' Cycloset (bromocriptine mesylate) has become the first new type 2 diabetes therapy to win US FDA licensing since the agency imposed stricter cardiovascular safety requirements for such drugs late last year.

Metabolic Disorders Cardiovascular
See All

Company Information

UsernamePublicRestriction

Register